Skip to content
Value Creatives
Proof — a platform we built and operate

We don’t just ship for clients. We run our own.

InsureLytix is a production platform our team designed, built, and operates — a payer-grade directory, network-adequacy, and member-portal system for U.S. health plans. It is one of our deepest proof points: evidence that we ship systems serious organizations run in production, not prototypes.

The product

Three modules. One operational source of truth.

A multi-tenant, white-label platform we run in production for U.S. health plans — directory accuracy, network adequacy, and a member-facing search surface, on one source of truth. Plans that want to operate it themselves license it directly.

Score every directory row, every month.

NPI registry cross-checks, automated decay alerts, and targeted phone outreach for high-volume specialties. The accuracy operations program we run for clients lives here.

  • 78/100 score gauge with 12-month trend
  • Match / Stale / Phantom row classification
  • Decay alerts with remediation queues
A clinician reviewing patient records on a tablet in a care setting
What's inside

The capability list, abbreviated.

Operations

Accuracy program orchestration

NPI registry cross-checks, credentialing-cycle integration, and targeted phone outreach. Designed to hold a 50K-row directory within 30 days of ground truth.

Compliance

CMS-aligned reporting

Audit protocol exports, Star Rating exposure modeling, and No Surprises Act tracking.

Integrations

Credentialing + claims feeds

Connectors for the most common credentialing platforms; X12 837/834 bridges where needed.

Surfaces

Member, broker, ops

Three audience-specific surfaces backed by one source of truth — no nightly extract reconciliation drama.

Security

HIPAA, BAA, audit

HIPAA-aligned vendor stack with BAA in place. Audit logs immutable for 7 years.

Two ways to start

Most clients don't license InsureLytix. Some do.

If you'd rather operate the directory yourself than hire us to operate it for you, that's the path. Talk to our team about licensing — we'll scope deployment on the working session.